The latest price target for Ardent Health Partners (NYSE:ARDT) was reported by Morgan Stanley on January 21, 2025. The analyst firm set a price target for $22.00 expecting ARDT to rise to within 12 months (a possible 54.39% upside). 20 analyst firms have reported ratings in the last year.

The latest analyst rating for Ardent Health Partners (NYSE:ARDT) was provided by Morgan Stanley, and Ardent Health Partners maintained their overweight rating.

There is no last upgrade for Ardent Health Partners

The last downgrade for Ardent Health Partners Inc happened on November 6, 2024 when B of A Securities changed their price target from $22 to $19 for Ardent Health Partners Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Ardent Health Partners, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Ardent Health Partners was filed on January 21, 2025 so you should expect the next rating to be made available sometime around January 21, 2026.

While ratings are subjective and will change, the latest Ardent Health Partners (ARDT) rating was a maintained with a price target of $23.50 to $22.00. The current price Ardent Health Partners (ARDT) is trading at is $14.25, which is out of the analyst’s predicted range.